Person’s chi-square test indicated that the combined expression of ANXA2 and GPC1 was dramatically associated with age (P < 0.001), WHO grade (P = 0.005), recurrence (P < 0.001), and survival status (P < 0.001) but not with gender or tumor location (Table 1). This evidence concerns the gene ANXA2 and neoplasm.